Vertex Pharmaceuticals

VRTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$130.872 B

$516.34 +0.26%

Close of 23 Sept 2026

Revenue

$12.0B

#370 by revenue

Earnings

$3.95B

#128 by earnings

Shares outstanding

253,460,924

Latest filing cover page

P/E ratio

33.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →

#8Novo Nordisk A SNVO$169.0B
#9PfizerPFE$160.6B
#10Vertex PharmaceuticalsVRTX$130.9B
#11Bristol Myers SquibbBMY$124.9B
#12SanofiSNY$101.6B

What if Vertex Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $29.8T

$117,757.51

Per share 228× higher

Bitcoin $1.69T

$6,683.95

Per share 12.9× higher

Nvidia $5.43T

$21,442.32

Per share 41.5× higher

Or at a round number

$200.0B $500.0B $1.00T $2.00T

Where these numbers come from

Share counts and financials for Vertex Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.